Freenome is a high-growth biotech company on a mission since 2014 to create tools that empower everyone to prevent, detect, and treat their disease.
To achieve this mission, Freenome is developing next-generation blood tests to detect cancer in its earliest, most treatable stages using our multiomics platform and machine learning techniques. Our first blood test will detect early-stage colorectal cancer and advanced adenomas.
We have raised more than $1.1 billion from leading investors like Perceptive Advisors, RA Capital Management, Roche Venture Fund, Kaiser Permanente, Novartis and the American Cancer Society’s BrightEdge Ventures.
A ‘Freenomer’ is a mission-driven employee who is fueled by the opportunity to make a positive impact on patients' lives, who thrives in a culture of respect and cross collaboration, and whose work makes a significant impact on the company and their career.
Company Details
- Employees
- 412
- Founded
- -
- Address
- 3000 Marina Blvd, Brisbane,california 94005,united States
- pr****@****ome.com
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- freenome.com
- Keywords
- molecular diagnostics, multiomics, machine learning, biotechnology, cancer screening, oncology, early cancer detection, computational biology.
- HQ
- Brisbane, California
Freenome Questions
Freenome's website is freenome.com
Freenome's LinkedIn profile is https://www.linkedin.com/company/freenome
Freenome has
412 employees.
View email and phone details for 412
employees at Freenome.
Freenome's industry is
Biotechnology Research
Freenome's top competitors are
Tempus Ai,
Guardant Health,
Grail,
Natera,
Bridgebio,
Owkin,
Insitro,
Machinify,
Vera Therapeutics, Inc.,
Dnanexus.
Freenome's support email address is press@freenome.com
Freenome's categories are Biotechnology Research
Freenome's founding year is 2014
